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Summary: To assess the quality of health care, patient outcomes associated with medical providers (e.g.
dialysis facilities) are routinely monitored in order to identify poor (or excellent) provider performance. Given
the high stakes of such evaluations for payment as well as public reporting of quality, it is important to assess
the reliability of quality measures. A commonly used metric is the inter-unit reliability (IUR), which is the
proportion of variation in the measure that comes from inter-provider differences. Despite its wide use, however,
the size of the IUR has little to do with the usefulness of the measure for profiling extreme outcomes. A large IUR
can signal the need for further risk adjustment to account for differences between patients treated by different
providers, while even measures with an IUR close to zero can be useful for identifying extreme providers. To
address these limitations, we propose an alternative measure of reliability, which assesses more directly the value
of a quality measure in identifying (or profiling) providers with extreme outcomes. The resulting metric reflects
the extent to which the profiling status is consistent over repeated measurements. We use national dialysis data
to examine this approach on various measures of dialysis facilities.
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Monitoring outcomes of health care providers is an important activity that has received
much attention in the literature (e.g. Normand et al. 1997; Normand and Shahian, 2007;
Jones and Spiegelhalter, 2011; He et al. 2013; Estes et al. 2018). In order to identify
extreme (poor or excellent) performance and to intervene as necessary, outcomes of
patients associated with health care providers are routinely monitored most often by
both government and private payers. This monitoring can help patients make more
informed decisions, and can also aid consumers, stakeholders, and payers in identifying
providers where improvement may be needed, and even closing or fining those with
extremely poor outcomes. Therefore, it is important that the quality measures used for
profiling providers are appropriate and one aspect of this is the measure’s reliability.
To assess the reliability of a quality measure, the inter-unit reliability (IUR) is commonly
used. The IUR specifies the proportion of the total variation in the quality measure that
can be attributed to the between-provider variation. The variation in a specific measure
across health care providers can be viewed as comprising two parts: the between-provider
variation and the within-provider variation. The IUR is then defined as the ratio of the
between-provider variance to the total variance.
Scholle et al. (2008) and Adams (2009) suggested that a quality measure should attain an
IUR of at least 0.7. This work has recently been discussed by the National Quality Forum
(NQF) as suggesting a possible guideline for assessing measure reliability. If the IUR is
large, it is argued that most of the variation observed between health care providers
is driven by systematic differences between the providers and not by the variation in
the outcomes of the patients being treated. Thus, it is argued that the measure gives
a reliable assessment of between-provider differences and could be used for the purpose
of assessing extreme providers. Note, however, that Kalbfleisch et al. (2018) discussed
several drawbacks of using the IUR to characterize the suitability of a measure for
profiling providers. In particular,
(1) The variation between providers may be due to various factors in addition to differ-
ences in the quality of the health care provided. Differences between providers can
also arise because there are important unmeasured characteristics such as patient
comorbidities or patient and provider demographics that are not within the control
of the provider and that differ across providers. Thus, a large IUR can be a signal of
incomplete risk adjustment and may not be much related to quality of care at all.
(2) The IUR may not determine the suitability of a measure for identifying outliers.













Even measures with an IUR close to zero can be very useful for identifying extreme
providers, whose outcomes do not conform to an assumed statistical model.
In this paper, we propose an additional metric of reliability that assesses more directly
the value of a quality measure in identifying providers with extreme outcomes. The
underlying idea is that we should consider a measure to be reliable if, on repeated appli-
cations, it profiles the same providers as being extreme with relatively high probability.
We proceed in two steps: first, we evaluate the ability of a measure to consistently profile
providers with extreme outcomes; second, we use the IUR to calibrate this new metric,
which we call the profile IUR (termed PIUR throughout this paper).
Our paper continues as follows: Section 2 first reviews the IUR for a simple linear model
and then defines the proposed PIUR for normally distributed patient outcomes. Section
3 exemplifies the PIUR for several commonly used profiling methods. In Sections 4 and 5,
we examine the proposed PIUR with simulations and national data on dialysis patients.
We conclude with a discussion in Section 6.
2. Profile IUR
2.1 A simple linear model and review of the IUR
Let Y ∗ij represents a continuous outcome for subject j in provider i, where i = 1, . . . ,m
and j = 1, . . . , ni. Here m is the total number of providers and ni is the sample size for
provider i. Consider an underlying linear regression model
Y ∗ij = µ+ αi + X
T
ijβ + εij, (1)
where αi∼N(0, σ2b ) is the provider effect, εij∼N(0, σ2w) is the random noise, and Xij is
a vector of patient characteristics. The regression coefficients, β, measure the within-
provider relationship between the covariates and the response. Here we assume that large
values of Y ∗ij correspond to poor outcomes.
In model (1), it is common to assume (at least implicitly) that Xij is independent
of αi. However, in practice, patient characteristics can be correlated with provider
attributes (e.g. patients with less favorable health status may be referred to providers
with poorer treatment strategies). In this case, the estimated regression coefficients based
on the usual likelihood analysis of the model (1) are biased. Alternatively, β can be
estimated in a model with fixed effects for provider-specific parameters, which avoids
the aforementioned issues of bias (Kalbfleisch and Wolfe, 2013). The resulting estimate
can then be used as an offset to estimate the remaining parameters and the αi’s.
We note that, in many profiling applications, the number of providers and the number












2 PROFILE IUR 2.2 Limitations of the IUR
of patients are large so that µ, σb, σw and β can be precisely estimated. To simplify the
notation, we proceed below as though their values are known. Let Yij = Y
∗
ij − µ−XTijβ
be the risk adjusted response, so that the model (1) becomes
Yij = αi + εij. (2)
An estimate of αi is Y i =
∑ni
j=1 Yij/ni, where Y i ∼ N(0, σ2b + σ2w/ni). Here σ2b is the
between-provider variance, and σ2w/ni is the within-provider variance.
The IUR for a provider with ni patients is the proportion of the total variation in Y i







which is also the square of the correlation between Y i and the true provider effect αi
IURi = Corr
2(Y i, αi).
Figure 1 plots the density of an example with two distributions of interest: the distri-
bution of the provider effects, αi, and the distribution of the estimated provider effects,
Y i. The IUR is the ratio of the variances of these two distributions.
To assess the average ability of a quality measure to distinguish between providers,
the overall IUR can be obtained from the decomposition of total variation in a one-
way ANOVA. Recall that the Between Sums of Squares (SSB) is defined as SSB =∑m






























2.2 Limitations of the IUR
The interpretation of the IUR depends on the sources of variation in the provider effects.
The argument that a relatively large value of the IUR is required to justify the use of
a measure for profiling is based on the assumption that the variation in the provider
effects is entirely due to the quality of care (Adams, 2009; Kalbfleisch et al. 2018). That
is, there are no unobserved confounders that are correlated with the outcome of interest
and whose values vary across providers. This assumption, however, is often invalid.
For example, unobserved socio-economic factors, comorbidities and genetic differences












2.3 A model with outliers and the PIUR 2 PROFILE IUR
of patients may differ substantially across providers and so contribute to the between-
provider variation. Thus, a large IUR can be a signal of incomplete risk adjustment.
Moreover, the IUR indicates the average ability of the measure to distinguish between
providers. In identifying providers that are outliers, however, we are not concerned with
this average, but rather with the measure’s ability to identify providers where outcomes
are extreme. Thus, a measure with a small IUR may still be useful in identifying a
few providers whose outcomes are extreme. These concerns motivate us to propose an
alternative measure of reliability, which emphasizes the identification of outliers.
2.3 A model with outliers and the PIUR
It is convenient to extend the model (1) to include contamination with outliers. Such a
model is considered by Efron (2013) for large-scale hypothesis testing. Suppose that the
provider effects are either from the null normal distribution, N(0, σ2b ) with probability
π0 or from a distribution of outliers with probability π1 = 1 − π0. Thus, we generalize
model (1) by taking
f(αi) = π0f0(αi) + π1f1(αi), (3)
where f0(α) is the N(0, σ
2
b ) density and f1(α) is a density for outliers with support on
the region α > C for some specified C > 0, say C = 2σb.
For provider profiling, it is natural to consider a quality measure as reliable if it is able
to reliably identify the same providers as extreme. Thus, we might assess a measure by
its propensity to identify the same providers as extreme when the data are replicated.
Replication is not possible in practice, so we consider a sample-splitting approach as
follows: Randomly divide each providers patients into two nearly equal-sized subgroups.
For a given threshold, determine whether each provider is identified as extreme in the
first and the second subgroups. Repeat this process a large number of times to estimate
the empirical probability that a provider is profiled in the second subgroup given that
it is profiled in the first. This empirical reflagging rate is then put on the IUR scale, by
determining the IUR that would yield this reflagging rate in the absence of outliers. The
difference between the PIUR and the IUR indicates the extent to which the measure
identifies outliers.
More specifically, given a data set, a quality measure and a profiling method, PIUR is
determined as follows:
Algorithm 1 (Definition of the PIUR)
(1) Randomly divide each provider’s patients into two nearly equal-sized sub-groups,
e.g. groups A and B.













(2) For a given threshold p and profiling method, determine whether the provider is
flagged based on data in groups A and B.
(3) Repeat this process a large number of times, and estimate the probability that a
provider is flagged in group B given that it is flagged in group A. This estimate is
the empirical reflagging rate θ̂B|A.
(4) Under the assumption that the data arise from the model (2) with no outliers, let
G(R) = Pr(provider is flagged in group B | provider is flagged in group A, IUR=R).
(5) The PIUR at level p is R̃ where G(R̃) = θ̂B|A.
As defined, the PIUR is on the same scale as the IUR, but with emphasis on the ability
of quality measures to consistently identify outliers. For example, for a given empirical
reflagging rate θ̂B|A, we solve the equation G(R) = θ̂B|A and find the R that leads to
the empirical reflagging rate θ̂B|A. The values of the PIUR, compared with the IUR, are
influenced by the proportion of outliers and their magnitude. That is, a higher PIUR
compared to the IUR indicates the presence of outlier providers, which is not captured
in the IUR itself.
3. Profiling Methods
In this section, we briefly review several commonly used profiling methods for flagging
extreme providers. We show that considering the provider-specific IUR provides a simple
theoretical justification for estimating the proposed PIUR for various profiling methods.
That is, assuming that the data arise from the model (2), the conditional probability for
the ith provider, Gi(R), depends only on the IURi.
3.1 Provider effects due entirely to variation in the quality of care
In these cases, it is natural to consider tests of sharp null hypotheses about the provider
effects. Generally one of two methods is used: fixed effects (FE) and random effects
(RE).
Under the linear model, the fixed effects Z-score for a test of αi = 0 is
ZFE,i = Y i/(σw/
√
ni).
Based on fixed effects, the ith provider is flagged as worse than expected if ZFE,i > zp,






FE,i be the FE-based Z-scores for the randomly chosen groups A and




FE,i are bivariate normal












3.2 Provider effects are due to incomplete risk adjustment3 PROFILING METHODS
with variance 1/(1 − ρ) and correlation ρ = R/(2 − R). The corresponding conditional
probability is summarized in Proposition 1.
Proposition 1 Under the linear model (2) with IURi = R and p ∈ (0, 1),
GFE,i(R) = Pr(Z
(B)
FE,i > zp | Z
(A)




where s1 = −zp
√
1− ρ, Φ and Φ2,ρ are the cumulative distribution functions of the
standard normal distribution and a bivariate normal distribution with variation 1 and
correlation ρ, respectively; e.g.,
















Alternatively, the RE approach is based on the best linear unbiased predictor (BLUP) or
empirical Bayes estimate arising from the “posterior” distribution of αi given the data.
The estimate of αi then is α̂RE,i = IURiY i, which has a posterior variance IURiσ
2
w/ni.














RE,i are bivariate normal with variance ρ/(1− ρ) and correlation
ρ.
Proposition 2 Under the linear model (2) with IURi = R, for a fixed p ∈ (0, 1),
GRE,i(R) = Pr(Z
(B)
RE,i > zp | Z
(A)




where s2 = s1/
√
ρ, and ρ is the same as in Proposition 1.
3.2 Provider effects are due to incomplete risk adjustment
If quality of care is not the main source of variation in the provider effects, the random
variation accounted for in σb should be incorporated in the profiling method. The
approach based on fixed effects with random intercept (FERE) (Jones and Spiegelhalter,
2011; Kalbfleisch et al. 2018) utilizes fixed-effects estimates but judges their values with
reference to the marginal distribution, including the between-provider variation. The





















3 PROFILING METHODS 3.3 Empirical null approach
One may flag provider i if ZFERE,i > zp. This approach is based on the assumption
that most of the between-provider variation is due to unobserved characteristics that
are outside the control of the provider. Thus, the FERE approach only flags a provider
if its outcome is extreme with reference to the total variation. This approach is useful










FERE,i are bivariate normal with variance 1 and covariance ρ.
Proposition 3 Under the linear model (2) with IURi = R and p ∈ (0, 1), the conditional
probability for the FERE approach is
GFERE,i(R) = Pr(Z
(B)
FERE,i > zp | Z
(A)




where s3 = −zp.
Note that Propositions 1-3 are based on provider-specific IUR. To assess the average
ability of a quality measure to consistently identify outliers across providers, we extend
the PIUR based on the overall IUR. Numerical evaluations for the proposed methods
are provided in Section 4.
3.3 Empirical null approach
The empirical null approach is based on work of Efron (2004, 2013) who defined the
empirical null and used it in problems of assessing false discovery rates. Kalbfleisch and
Wolfe (2013) proposed the use of the empirical null in profiling health care providers.
We suppose first that all providers are approximately of the same size so that ni ≈ n for
all i. In the empirical null approach, a normal distribution is fitted to the central part
of the distribution of the fixed effects Z-scores, ZFE,i, i = 1, . . . ,m. This can be done
using robust methods that are not influenced by values in the tail of the distribution.
For example, one might use M-estimation or maximum likelihood approaches based
on a truncated normal model (e.g. Efron, 2013). The resulting estimates of the mean
and variance are µ̂M and σ̂
2
M , and the empirical null distribution is N(µ̂M , σ̂
2
M). This
distribution, instead ofN(0, 1) is used as the null hypothesis with which to assess extreme
values of the FE-Z-scores. More specifically, the ith provider is flagged as worse than
expected if ZFE,i > µ̂M + zpσ̂M , where zp is the upper pth quantile of the standard
normal distribution.
If the model (2) is exactly true for all providers, the empirical null approach and the
FERE approach give essentially the same solution. This follows from the results of
Andrews et al. (1972) and Huber (1964, 1973), which can be used to show that µ̂M → 0

















w/n as the number of providers
m→∞. More generally, however, the empirical null approach also applies to the model
(3) where it gives asymptotically correct results, whereas FERE will result in potentially
biased estimates of the intercept and σ2b . As a consequence of the asymptotic equivalence
of the empirical null approach and the FERE approach when the model (2) is exactly
true, the PIUR of the empirical null approach can be computed by referring the empirical
reflagging rate to GFERE(R). The dependence of the empirical null on sample size can be
handled by stratifying the facilities into relatively homogeneous strata as in Kalbfleisch
and Wolfe (2013) and He et al. (2013). In addition, we have been developing smoothed
estimates of the mean and variance of the Z-scores as a function of sample size so that
each provider has an individualized empirical null distribution.
One major advantage of the empirical null approach over FERE or RE is that it
generalizes relatively easily to other non-linear examples where the FE-based Z-scores
are approximately normal for relatively large ni. Thus, this approach can be used for
example in situations where the response is binary as in He et al. (2013) and Estes et
al. (2018) or a failure time as in Kalbfleisch and Wolfe (2013) and in our example in
Section 5.
4. Numerical Evaluation
In this section, we examine the properties of the proposed PIUR through numerical
evaluation. We consider the FERE-based Z-scores for an one-sided test with a significance





′ = 1. We
vary the magnitude of the between-provider variance, σ2b , such that ordinary IUR takes
values 0.00, 0.25 and 0.50. We assume that the provider effects are either from the null
normal distribution N(0, σ2b ) with probability π0, or from a distribution of outliers with
probability π1 = 1 − π0. We vary the value of π1 from 0.00, 0.01, 0.02 and 0.05. The
magnitude for these outlier provider effects are fixed taking values γ times σT , where
γ = 2, 3 or 4 and σT = 1.
Table 1 shows the theoretical values of the PIUR for various values of IUR, where the
theoretical values are calculated based on the assumed distribution. For example, for
a given value of IUR, the corresponding conditional probabilities for the FERE-based
Z-scores can be computed as
Pr(Z
(B)
FERE,i > zp | Z
(A)
FERE,i > zp, IURi = R) =
π0Φ2,ρ(−zp,−zp) + π1Φ2 (s)
π0Φ(−zp) + π1Φ(s)
,




















The results shown in Table 1 suggest that, even when the IUR is small, relatively high
PIUR can occur for settings including contamination with outliers. For example, even
when the IUR= 0.00, if the proportions of outliers are set at 5% with the magnitude
for these outlier provider effects taking values 2, 3 or 4 times σT , the corresponding
FERE-based PIURs are 0.56, 0.81 and 0.93, respectively.
We next consider a linear model framework with 1, 000 providers and ni = 100 patients
per provider. The continuous outcome, Yij, is generated from the linear model (2) with
σ2w = 1. The magnitude for these outlier provider effects are fixed taking values γ times
σT , where γ = 4. The remaining set ups are the same as those in Table 1. Table 2 shows
that the empirical values of the profile IUR are close to the corresponding theoretical
values.
To assess the proposed methods in settings with various sample sizes across providers,
we consider a linear model framework with 1, 000 providers and ni generated from a
normal distribution with mean 100 and standard deviation 50 and then rounded to the
nearest integer values. To avoid extremely small provider sizes, we set ni as 10 if the
rounded integer value is less than 10. Table 3 shows that the empirical values of the
profile IUR are close to the corresponding theoretical values.
5. Application
In 2016, more than 120,000 patients were diagnosed with end-stage renal disease (ESRD)
(Saran et al. 2018), with kidney dialysis as the most common treatment option. In order
to monitor the performance of dialysis facilities, several risk-adjusted quality measures
have been implemented by the Centers for Medicare and Medicaid Services (CMS) on
the Dialysis Facility Compare (DFC) site and in the ESRD Quality Incentive Program,
which is a CMS value-based purchasing program. In this section, we apply the PIUR to
two quality measures that are reported on the DFC site.
5.1 Standardized Mortality Ratio
The Standardized Mortality Ratio (SMR) is a risk-adjusted measure that is used to
evaluate whether facility-specific mortality rates are in line with the national average
across all Medicare certified US dialysis facilities. The SMR for facility i is defined as
SMRi = Oi/Ei, where Oi is the observed number of deaths in facility i, and Ei is the
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corresponding expected number of deaths for patients in this facility computed under
a population norm. An SMR less (greater) than 1 indicates that the facility’s observed
death rate is less (greater) than expected based on overall national rates with adjustment
for the measured characteristics of patients in this facility.
For practical implementation, the SMR is computed from a two-stage model: In the
first stage, a Cox model stratified by facilities is used to estimate regression parameters
associated with patient characteristics. This model assumes that the hazard function
is λij(t) = λ0i(t) exp{XTijβ}, where λ0i is the facility-specific baseline hazard. This
stratified approach avoids any problems that might arise when patient characteristics
are correlated with facility effects. In the second stage, the regression parameters are
used as an offset in an unstratified Cox model to estimate the baseline failure rate at
the “average” facility. The expected number of events for the jth patient in the ith
facility, denoted by Eij, is calculated as Eij =
∫ τ
0
Rij(t) exp{XTijβ̂}dΛ̂0(t), where τ is
the maximal follow-up time, XTijβ̂ is treated as an offset with β̂ estimated from stage 1,
Λ̂0(t) is the “population-average” cumulative baseline hazard, and Rij(t) is the at-risk
process. The expected number for facility i is then computed as Ei =
∑ni
j=1Eij. The
corresponding p-value can be computed using a Poisson approximation under which the
Oi, under the null hypothesis that the facility’s death rate is the same as the population
average, follows a Poisson distribution with mean Ei.
We use SMR data collected from the four year period (2013-2016). Methods of profiling
are based on the empirical null approach. A total of 5,965 facilities are included in the
analysis, after excluding facilities with fewer than 3 expected deaths. The number of
observed deaths per facility ranges from 0 to 418, and the number of expected deaths
ranged from 3 to 309. Figure 2a shows a histogram of the SMR.
The IURs for SMR were computed based on the approach proposed by He et al. (2019).
Based on one-year data, the IURs had a range of 0.22 − 0.25, which indicates that
about one-fourth of the variation in the SMR can be attributed to the between-facility
differences and about three-fourths to within-facility variation. Based on four years of
data (2013-2016), the IUR for SMR increased to 0.53, which indicates that about half
of the variation in the measure can be attributed to the between-facility differences and
about half to within-facility variation. In comparison, with p-value of 0.025 and using
the empirical null approach, the estimated conditional probability of being flagged again
is θ̂B|A = 0.22, and the corresponding PIUR is R̃ = 0.62, which is computed based on
the tabular theoretical values; e.g. GFERE(R̃) = 0.22, where GFERE(R̃) is defined in
Proposition 3. Note that in Table 1, when the IUR= 0.50, if the proportions of outliers
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are set at 2% with the magnitude for these outlier provider effects taking values 2 times
σT , the corresponding PIUR is also 0.62. Thus, when there are outlier facilities, the
PIUR tends to be larger than the IUR.
5.2 Standardized Readmission Ratio
An unplanned hospital readmission is defined as any unplanned hospital admission that
occurs within 30 days of discharge from a previous admission. Readmissions are expen-
sive. High readmission rates are indicators of poor care, leading to patient morbidity
and poor quality of life, and can be prevented through effective post-discharge early
intervention and care coordination (Chan et al. 2009). The standardized readmission
ratio (SRR) is a measure of dialysis facility-level hospital readmission among ESRD
dialysis patients. It is computed as SRRi = Oi/Ei, where Oi =
∑ni
j=1 Yij is the number
of observed readmissions, and Ei =
∑ni
j=1Eij is the expected number in facility i. Here
Yij is the observed outcome for the jth discharge in facility i, and Eij denotes the cor-
responding model-based expected outcome, accounting for patient-level characteristics
and assuming the facility-specific event rate equals the population rate. Specifically,
readmission rates are modeled using a logistic model:
logit(Pij) = log(Pij/(1− Pij)) = αi + XTijβ, (4)
where Pij = P (Yij = 1|αi,Xij), the parameters αi correspond to the fixed facility effect
and β is a vector of regression parameters. The expected number is computed as




1 + exp(α̂M + XTijβ̂)
,
where β̂ is the estimate of β and α̂M denotes the median of all estimated facility effects.
Similar to the interpretation of SMR, an SRR less (greater) than 1 indicates that the
facility’s observed readmission rate is less (more) than expected based on national rates.
Figure 2b shows the histogram of SRRs for 5,740 dialysis facilities in 2016. The IUR
had a value of 0.49, which indicates that about half of the variation in the SRR can be
attributed to the between-facility differences and about half to within-facility variation.
In contrast, with p-value of 0.025 and using the empirical null approach, the profile IUR
is 0.74, which indicates the existence of outlier facilities. For example, in Table 1, when
the IUR= 0.50, if the proportions of outliers are set at 5% with the magnitude for these
outlier provider effects taking values 2 times σT , the corresponding PIUR is 0.70. Thus,
the difference between the PIUR and the IUR indicates the presence of outlier providers













and, hence assesses more directly the ability of a quality measure for identifying outlier
providers.
Note that although the IUR (0.53) for the SMR based on four years of data is larger than
the IUR (0.49) for the SRR based on one year of data, the difference between the PIUR
and the IUR for SRR is larger than that for SMR. This indicates a larger proportion
and/or higher magnitudes of outliers providers for SRR, which is not captured in the
IUR itself.
6. Discussion
The IUR is a metric that specifies the proportion of variation in the quality measure
that is due to the between-provider variation. If all between-provider variation is due
to quality of care and all patients and providers follow the assumed linear model, the
IUR may be a reasonable signal to noise metric for a quality measure. However, in
settings where the main source of between-provider variation is due to incomplete risk
adjustment or the main focus of the provider profiling is to identify outliers, the role
of the IUR is limited. In fact, the IUR is based on the whole distribution of provider
effects, and can be a poor indicator to assess the ability of a measure to identify outliers
(Staggs, 2017; Staggs and Cramer, 2016; Kalbfleisch et al. 2018). Given that, the IUR
may not be an appropriate metric for assessing the performance of a quality measure.
In other words, the value of the IUR may not determine the suitability of a measure for
identifying outliers; even measures with a small IUR can be very effective for identifying
extreme providers, while a large IUR can be a signal of incomplete risk adjustment.
In this paper we assume that one main purpose of reporting quality measures is to
reliably identify very good and very poor providers. To address the problems associated
with the IUR, we propose an additional measure of reliability. The proposed PIUR is not
designed to address the problem of “no unobserved confounders.” Instead, it is designed
to assess the ability of quality measures to consistently identify outliers. Whether there
are unobserved confounders or not, the values of the PIUR, compared with the IUR, are
influenced by the proportion of outliers and their magnitude.
As proposed, the scale of the IUR is used to quantify the proposed PIUR, while the PIUR
takes into account the providers with extreme outcomes. We have shown that the PIUR
can be effective at assessing whether a quality measure reliably profiles outlier providers,
even under low values of the IUR. If there are no outliers, one should expect the PIUR to
be the same as the IUR. In cases where there are outlier providers, even measures with
an IUR close to 0 can have relatively high PIUR and can be very useful for identifying













extreme providers. Therefore, when the emphasis is on identifying “extreme” providers,
the difference between the proposed PIUR and the IUR indicates the usefulness of the
measure for profiling. In contrast, the size of the IUR or the PIUR value alone may not
be a reasonable indicator of the use of a quality measure for identifying very good or
poor providers. Therefore, we do not recommend a threshold for IUR or PIUR.
The values of the PIUR depend on the profiling method for flagging extreme providers.
Both the commonly used FE and RE approaches assume that the provider effects are the
consequence of variation in the quality of treatment and are under the full control of the
providers. As a result, they will tend to identify as worse than expected, large providers,
even when their true effect is not extreme. In contrast, the FERE approach is based
on the assumption that most of the between-provider variation is due to unobserved
characteristics that are outside the control of the provider. Both of these extreme
assumptions are typically invalid, and the provider effects correspond to a combination of
quality of care and incomplete risk adjustment. Unfortunately, the source of the provider
effect cannot be identified on the basis of the data alone and can only be estimated based
on expert opinion. The article, Kalbfleisch et al. (2018) gives some discussion of how the
various methods depend on the source of the variation. The empirical null approach
has the advantage of leading to robust estimates of the between-provider variance by
limiting the influence of extreme observations. Additional discussion on this point can
be found in Kalbfleisch and He (2018) and a working manuscript by Xia et al. (2019).
The covariates in our motivating settings are patient-level, not provider level. However,
a covariate may have both a between-provider component, which we might summarize in
terms of X i, the provider-specific mean for provider i, and a within-provider component
Xij −X i. This leads to differing within-provider and between-provider covariate effects
as is discussed in Neuhaus and Kalbfleisch (1998). When provider effects are correlated
with covariates, it should also be noted that use of a random effects model can yield
a biased estimate of β (Pan, 2002; Kalbfleisch and Wolfe, 2013). The β that we are
adjusting for is the within-provider effect; one way to estimate that is to use a fixed
effects model.
As illustrated in Section 5, the proposed method can also be applied to complex quality
measures used in non-linear models. Specifically, He et al. (2019) have developed methods
to extend the IUR to such models. The empirical null approach described in Section 3.3
has been generalized to binary logistic model (He et al. 2013) and the Cox proportional
hazards model (Kalbfleisch and Wolfe, 2013). Thus, the empirical null-based PIUR can
be easily computed to such non-linear examples.
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Figure 1: The solid line is the distribution of the true provider effect, αi, and the dotted
line is the distribution of the estimated provider effect, Y i, in the example with σw =
10, σb = 0.5 and ni = 100. The IUR compares the variance of the former distribution
to that of the latter.















Figure 2: Histograms of SMR and SRR; the SMR figure is based on 5,965 dialysis
facilities with expected deaths greater than or equal to 3; the SRR figure is based on
5,740 facilities with numbers of index discharges greater than 10.















2σT 3σT 4σT 2σT 3σT 4σT 2σT 3σT 4σT
0% 0.00 0.25 0.50
1% 0.27 0.55 0.71 0.41 0.64 0.77 0.57 0.75 0.83
2% 0.39 0.73 0.83 0.49 0.79 0.87 0.62 0.83 0.90
5% 0.56 0.81 0.93 0.61 0.86 0.94 0.70 0.91 0.97
Table 1: Profile IUR (PIUR) with various percentages of outliers; the magnitude for
these outlier provider effects are fixed taking values γ times σT , where γ = 2, 3 or 4; the
results are based on p-value of 0.025 using the FERE approach.













True IUR Outliers Total-ÎUR EN-ÎUR PIUR FERE-P̂IUR EN-P̂IUR
0.25
0% 0.25 0.21 0.25 0.26 0.28
1% 0.35 0.23 0.77 0.79 0.76
2% 0.42 0.23 0.87 0.89 0.87
5% 0.57 0.25 0.94 0.96 0.94
0.50
0% 0.50 0.47 0.50 0.51 0.52
1% 0.56 0.49 0.83 0.85 0.83
2% 0.61 0.49 0.90 0.93 0.90
5% 0.71 0.50 0.97 0.98 0.97
Table 2: Profile IUR (PIUR) with various percentages of outliers; same sample size
across providers; Total-ÎUR: estimated IUR based on total between-provider variation;
EN-ÎUR: estimated IUR based on the estimated null distribution; PIUR: True PIUR;
FERE-P̂IUR: using the FERE approach; EN-P̂IUR: using the empirical null approach;
based on p-value of 0.025.













True IUR Outliers Total-ÎUR EN-ÎUR PIUR FERE-P̂IUR EN-P̂IUR
0.25
0% 0.24 0.22 0.25 0.23 0.29
1% 0.34 0.24 0.77 0.79 0.77
2% 0.41 0.25 0.87 0.89 0.86
5% 0.57 0.25 0.94 0.95 0.94
0.50
0% 0.50 0.48 0.50 0.50 0.59
1% 0.56 0.49 0.83 0.84 0.83
2% 0.61 0.50 0.90 0.92 0.90
5% 0.71 0.49 0.97 0.98 0.97
Table 3: Profile IUR (PIUR) with various percentages of outliers; various sample size
across providers; Total-ÎUR: estimated IUR based on total between-provider variation;
EN-ÎUR: estimated IUR based on the estimated null distribution; PIUR: True PIUR;
FERE-P̂IUR: using the FERE approach; EN-P̂IUR: using the empirical null approach;
based on p-value of 0.025.













Measure Year ÎUR P̂IUR Number of facilities
SMR 2013 0.24 0.36 5,424
2014 0.25 0.39 5,585
2015 0.22 0.42 5,770
2016 0.23 0.38 5,963
2013-2016 0.53 0.62 5,965
SRR 2016 0.49 0.74 5,740
Table 4: Estimated IUR and Profile IUR (PIUR) for SMR and SRR; with p-value of
0.025; and using the empirical null approach.
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